University of Arizona researchers are ready to launch a long-delayed human clinical trial on a drug they hope will cure valley fever.Nikkomycin Z, discovered in the 1970s, will be tested in Tucson on people diagnosed with fresh cases of valley fever to show the drug’s safety and offer insights on its effectiveness, said Dr. John Galgiani, director of the Valley Fever Center for Excellence.
